Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mateos-Soria AS"'
Autor:
Haydee C. Verduzco-Aguirre, Carolina Gomez-Moreno, Ana P. Navarrete-Reyes, Gretell Henriquez-Santos, Javier Monroy Chargoy, Abigail Mateos-Soria, Juan José Sánchez-Hernández, Alicia Castelo-Loureiro, Liz Hamui-Sutton, Melchor Sánchez-Mendiola, Enrique Soto-Perez-de-Celis
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSETo develop and implement a continuing professional development (CPD) activity focused on geriatric assessment (GA) in oncology for oncologists and geriatricians. We evaluated the impact of this activity on knowledge, skills, and performance re
Externí odkaz:
https://doaj.org/article/0697f962256d47fa9d8396392de5c01b
Autor:
Cano-Cruz, Lilian Guadalupe, Barrera-Vargas, Ana, Mateos-Soria, Abigail, Soto-Perez-de-Celis, Enrique, Merayo-Chalico, Javier
Publikováno v:
In Archives of Medical Research February 2022 53(2):113-121
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Verduzco-Aguirre HC; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Gomez-Moreno C; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Navarrete-Reyes AP; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Henriquez-Santos G; Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Monroy Chargoy J; Hospital Juárez de México, Mexico City, Mexico., Mateos-Soria A; Instituto Nacional de Cancerología, Mexico City, Mexico., Sánchez-Hernández JJ; Hospital de Oncología, Centro Médico Nacional Siglo XXI, Mexico City, Mexico., Castelo-Loureiro A; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Hamui-Sutton L; Universidad Nacional Autónoma de México, Mexico City, Mexico., Sánchez-Mendiola M; Universidad Nacional Autónoma de México, Mexico City, Mexico., Soto-Perez-de-Celis E; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; University of Colorado Anschutz Medical Campus, Aurora, CO.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2024 Oct; Vol. 10, pp. e2400258. Date of Electronic Publication: 2024 Oct 17.
Autor:
Abigail, Mateos-Soria, Francisco Javier, Castro-Alonso, Yusuf, Senser, Gabriel, Quintero-Bustos, Mariana, Licano-Zubiate, Rene, Bourlon, Elaine T, Lam, María T, Bourlon
Publikováno v:
Oncology (Williston Park, N.Y.). 36(4)
A previously healthy woman, aged 38 years, presented with a 3-month history of fatigue, dyspnea on exertion, significant weight loss, and severe left flank pain; her symptoms restricted any work activities. Laboratory test results were notable for hy
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Enrique Soto-Perez-de-Celis, Ana Barrera-Vargas, Abigail Mateos-Soria, Javier Merayo-Chalico, Lilian Guadalupe Cano-Cruz
Publikováno v:
Archives of medical research. 53(2)
Latin America is experiencing a demographic and epidemiological transition, with an increase in non-communicable diseases such as cancer. One of the greatest advances in the therapeutic approach to cancer has been the discovery of immunotherapy, and
Autor:
Mateos-Soria A, Castro-Alonso FJ, Senser Y, Quintero-Bustos G, Licano-Zubiate M, Bourlon R, Lam ET, Bourlon MT
Publikováno v:
Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2022 Apr 06; Vol. 36 (4), pp. 221-225.
Autor:
L Diaz-Nieto, E Soto-Perez-de-Celis, N Jacobo-Herrera, JL Ventura-Gallegos, A Zentella-Dehesa, RA Garcia-Becerra, AS Mateos-Soria, Y Chávarri-Guera
Publikováno v:
Cancer Research. 76:P5-04
Introduction: Despite recent advances in therapy, additional options for improving the outcomes of patients with HER2-overexpressing breast cancer (BC) are needed. The role of vitamin D in relation to BC outcomes is controversial. Both calcitriol and